The effect of the Russian combined vector vaccine against the novel coronavirus infection caused by SARS-CoV-2 on ovarian reserve and menstrual function in reproductive-aged women

Dolgushina, Dolgushina N.V.; Dovgan, Dovgan A.A.; Drapkina, Drapkina Yu.S.; Ivanets, Ivanets T.Yu.; Vtorushina, Vtorushina V.V.; Gus, Gus A.I.; Sukhikh, Sukhikh G.T.

doi:10.18565/aig.2022.4.115-122

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Eight studies investigated the effect of SARS‐CoV‐2 infection on AMH levels 26–36 . Ten studies investigated the possible effect of COVID‐19 vaccination on AMH levels 16,34–42 . Six studies used m‐RNA vaccines, one used the Russian GAM‐COVID vaccine, two studies used CoronaVacc, and two did not report the type of vaccines used.…”

Section: Resultsmentioning

confidence: 99%

“… 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 Ten studies investigated the possible effect of COVID‐19 vaccination on AMH levels. 16 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 Six studies used m‐RNA vaccines, one used the Russian GAM‐COVID vaccine, two studies used CoronaVacc, and two did not report the type of vaccines used. All studies were observational, including prospective and retrospective studies.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

The effect of COVID‐19 and COVID‐19 vaccination on serum anti‐Mullerian hormone: A systematic review and meta‐analysis

Ghaemi,

Hantoushzadeh,

Shafiee

et al. 2024

Immunity Inflam & Disease

View full text Add to dashboard Cite

ObjectiveThe current study aims to evaluate the impact of COVID‐19 infection and vaccination on ovarian reserve by detecting the anti‐Mullerian hormone (AMH) level.MethodPubMed, Embase, Web of Science, and Scopus has been searched for studies assessing the effect of COVID‐19 infection and/or vaccination on AMH levels up to February 27, 2023. Based on PRISMA 2020 statement criteria, a systematic review and meta‐analysis of included studies were performed. The studies' quality was assessed by the National Institute of Health (NIH) quality assessment tool. The standardized mean difference (MD) of the AMH level was used and the quantitative values of each study were pooled separately by using a random effect model.ResultsOut of 246 studies screened, 18 were included in the systematic review and 14 in the meta‐analysis. Included studies were published between 2021 and 2022 and were conducted in different countries, including the USA (n = 3), China (n = 2), Russia (n = 2), Turkey (n = 5), Israel (n = 3), Czech (n = 2), and Spain (n = 1). Eight studies investigated the effect of SARS‐CoV‐2 infection on AMH levels, and ten studies investigated the possible effect of COVID‐19 vaccination on AMH levels. The pooled analysis showed a statistically significant decrease in AMH levels after COVID‐19 infection (SMD: −0.24; 95% CI: −0.36 to −0.11; I2 = 0%; p = .0003). Vaccination analysis showed a nonstatistically significant change in AMH levels after COVID‐19 vaccination (SMD: −0.11; 95% CI: −0.25 to 0.04; I2 = 35%; p = .14).ConclusionCOVID‐19 infection can result in ovarian reserve injury by reducing the AMH level but getting vaccinated against COVID‐19 has no impact on the AMH level.

show abstract

Section: Resultsmentioning

confidence: 99%